This is the authors' abstract. We don't add key points for this paper.
C) and HRMS. The in vitro cytotoxicity study revealed their biocompatibility. Amongst the UFAs, only PA and LLA exhibited transdermal enhancer potential [enhancement ratio (ER) of 1.35 and 2.9 respectively]. All synthesized derivatives at 1% w/w were found to be more effective enhancers as compared to their parent UFAs, with LLA1E being identified as the most superior (ER = 5.31). Further, the concentration effect study revealed that at 2% w/w LLA1E had a greater ER (6.11) as compared to its parent (ER = 3.85). The permeability data correlated with the observations made in the histomorphological and transepithelial electrical resistance (TEER) evaluations. There was no significant loss in the integrity of the epidermis, transcellular and intercellular route of transport across the epidermis, with drug and enhancer treatment having no permanent damage on the epidermis. The novel dendritic ester derivatives of the UFAs therefore can be considered as effective transdermal permeation enhancers.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rambharose et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: